# Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

> **NCT00906828** · PHASE4 · COMPLETED · sponsor: **Uppsala University** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** levodopa/carbidopa
- **DRUG:** entacapone
- **DRUG:** tolcapone

## Key facts

- **NCT ID:** NCT00906828
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906828, "Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00906828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*